2017
DOI: 10.1111/apt.14029
|View full text |Cite
|
Sign up to set email alerts
|

Letter: the coeliac stomach – a significant increase in tissue transglutaminase antibodies is associated with gastritis

Abstract: Linked ContentThis article is linked to Banaszkiewicz et al paper. To view this article visit https://doi.org/10.1111/apt.13789.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 9 publications
0
1
0
Order By: Relevance
“…Interestingly, the cases with gastritis had higher antibody titers regardless of the extent of villous atrophy. The article suggested that this could be due to having a longer duration of the disease or a potential role of gastric mucosa in gluten-mediated immune reactions (13). In our study, among 39 patients with positive celiacspecific antibodies, 27 were histopathologically proven CD, and all of these patients had chronic gastritis.…”
Section: Celiacmentioning
confidence: 52%
“…Interestingly, the cases with gastritis had higher antibody titers regardless of the extent of villous atrophy. The article suggested that this could be due to having a longer duration of the disease or a potential role of gastric mucosa in gluten-mediated immune reactions (13). In our study, among 39 patients with positive celiacspecific antibodies, 27 were histopathologically proven CD, and all of these patients had chronic gastritis.…”
Section: Celiacmentioning
confidence: 52%
“…Furthermore, AAG has been associated with other autoimmune diseases, particularly autoimmune thyroid diseases [5-7], type I diabetes mellitus [8, 9], vitiligo [10], Addison disease [11], and presumably also coeliac disease (CeD) [12, 13]. Interestingly, some recent studies reported that patients with CeD present alterations of gastric histology and gastric function [14, 15], describing a correlation between gastric mucosal changes and the presence of anti-transglutaminase antibodies [16]. Miceli and colleagues [12] found a 9.1% prevalence of CeD amongst patients affected by AAG, while the figure was much smaller in Kalkan’ s experience (3.4%) [17].…”
Section: Introductionmentioning
confidence: 99%